Genocea Biosciences, Inc.
GNCADelisted Jun 2, 2022- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001457612
Genocea Biosciences, Inc. was delisted on Jun 2, 2022; its insiders filed their last Form 4 on Jun 3, 2022; 40 institutions reported holding it in 13F filings for Q1 2022, worth $42.1M in total; no superinvestor held it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Genocea Biosciences, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Genocea Biosciences, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Duvall Diantha | CHIEF FINANCIAL OFFICER | 75,388 | Jun 3, 2022 | 0 |
| Flechtner Jessica Baker | Chief Scientific Officer | 89,027 | Jun 3, 2022 | 0 |
| Clark William D | President and CEO | 304,377 | Jun 3, 2022 | 0 |
| Sumer Jacquelyn L | CHIEF LEGAL & COMPLIANCE OFF | 43,000 | Jun 2, 2022 | 0 |
| Siber George | Director | 252 | Jun 1, 2022 | 0 |
| Walker Paul Edward | 10% Owner | 0Indirect | May 26, 2022 | 0 |
| Sonsini Peter W. | 10% Owner | 0Indirect | May 26, 2022 | 0 |
| Sandell Scott D | 10% Owner | 0Indirect | May 26, 2022 | 0 |
| New Enterprise Associates 16, L.P. | 10% Owner | 0 | May 26, 2022 | 0 |
| NEA Partners 16, L.P. | 10% Owner | 0 | May 26, 2022 | 0 |
| Nea 16 GP, LLC | 10% Owner | 0 | May 26, 2022 | 0 |
| Makhzoumi Mohamad | 10% Owner | 0Indirect | May 26, 2022 | 0 |
| Florence Anthony A. Jr. | 10% Owner | 0Indirect | May 26, 2022 | 0 |
| Chang Carmen | 10% Owner | 0Indirect | May 26, 2022 | 0 |
| Behbahani Ali | Director, 10% Owner | 0Indirect | May 26, 2022 | 0 |
| Baskett Forest | 10% Owner | 0Indirect | May 26, 2022 | 0 |
| Stapleton Raymond D Jr | CHIEF TECHNOLOGY OFFICER | 43,750 | May 26, 2022 | 0 |
| Davis Thomas Andrew | CHIEF MEDICAL OFFICER | 68,330 | Apr 5, 2022 | 0 |
| Aakalu Girish N | CHIEF BUSINESS OFFICER | 74,459 | Apr 5, 2022 | 0 |
| Lunger John | Director | – | Mar 7, 2022 | 0 |
| Herron Jennifer Lyn | Director | – | Sep 28, 2021 | 0 |
| Bate Kenneth | Director | – | Jul 2, 2021 | 0 |
| Schwab Gisela | Director | – | Jul 2, 2021 | 0 |
| Higgins Michael J | Director | – | Jul 2, 2021 | 0 |
| Bosley Katrine | Director | – | Jul 2, 2021 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 3, 2022 (view filing)4:13 PM ET | Jun 2 | 1 day | Duvall DianthaCHIEF FINANCIAL OFFICER | SSale | −1.35K | $0.06 | −$81.3 | −1.8%75.4K after | |
| Jun 3, 2022 (view filing)4:12 PM ET | Jun 2 | 1 day | Flechtner Jessica BakerChief Scientific Officer | SSale | −1.58K | $0.06 | −$94.68 | −1.7%89.0K after | |
| Jun 3, 2022 (view filing)4:11 PM ET | Jun 2 | 1 day | Clark William DPresident and CEO | SSale | −4.02K | $0.06 | −$241.38 | −1.3%304.4K after | |
| Jun 2, 2022 (view filing)4:32 PM ET | Jun 1 | 1 day | Sumer Jacquelyn LCHIEF LEGAL & COMPLIANCE OFF | SSale | −2.50K | $0.0601 | −$150.25 | −5.5%43.0K after | |
| Jun 2, 2022 (view filing)4:31 PM ET | May 31 | 2 days | Clark William DPresident and CEO | SSale | −117.2K | $0.0617 | −$7.23K | −27.5%308.4K after | |
| Jun 1, 2022 (view filing)4:11 PM ET | May 27 | 5 days | Siber GeorgeDirector | SSale | −20.4K | $0.0653 | −$1.33K | −98.8%252 after | |
| May 26, 2022 (view filing)6:32 PM ET | May 24-25 | 2 days | Walker Paul Edward10% Owner | SSale | −10.4M | $0.0723 | −$750.7K | −100.0%0 after | 2 lotsDuplicate filing |
| May 26, 2022 (view filing)6:31 PM ET | May 24-25 | 2 days | Sonsini Peter W.10% Owner | SSale | −10.4M | $0.0723 | −$750.7K | −100.0%0 after | 2 lotsDuplicate filing |
| May 26, 2022 (view filing)6:29 PM ET | May 24-25 | 2 days | Sandell Scott D10% Owner | SSale | −10.4M | $0.0723 | −$750.7K | −100.0%0 after | 2 lotsDuplicate filing |
| May 26, 2022 (view filing)6:26 PM ET | May 24-25 | 2 days | New Enterprise Associates 16, L.P. and 2 others10% Owner | SSale | −10.4M | $0.0723 | −$750.7K | −100.0%0 after | 2 lotsDuplicate filing |
| May 26, 2022 (view filing)6:25 PM ET | May 24-25 | 2 days | Makhzoumi Mohamad10% Owner | SSale | −10.4M | $0.0723 | −$750.7K | −100.0%0 after | 2 lotsDuplicate filing |
| May 26, 2022 (view filing)6:23 PM ET | May 24-25 | 2 days | Florence Anthony A. Jr.10% Owner | SSale | −10.4M | $0.0723 | −$750.7K | −100.0%0 after | 2 lotsDuplicate filing |
| May 26, 2022 (view filing)6:21 PM ET | May 24-25 | 2 days | Chang Carmen10% Owner | SSale | −10.4M | $0.0723 | −$750.7K | −100.0%0 after | 2 lotsDuplicate filing |
| May 26, 2022 (view filing)6:19 PM ET | May 24-25 | 2 days | Behbahani AliDirector, 10% Owner | SSale | −10.4M | $0.0723 | −$750.7K | −100.0%0 after | 2 lotsDuplicate filing |
| May 26, 2022 (view filing)6:16 PM ET | May 24-25 | 2 days | Baskett Forest10% Owner | SSale | −10.4M | $0.0723 | −$750.7K | −100.0%0 after | 2 lots |
| May 26, 2022 (view filing)4:15 PM ET | May 25 | 1 day | Stapleton Raymond D JrCHIEF TECHNOLOGY OFFICER | SSale | −2.50K | $0.089 | −$222.5 | −5.4%43.8K after | |
| May 26, 2022 (view filing)4:13 PM ET | May 25 | 1 day | Flechtner Jessica BakerChief Scientific Officer | SSale | −16.5K | $0.0881 | −$1.46K | −15.4%90.6K after | |
| May 26, 2022 (view filing)4:11 PM ET | May 26 | Same day | Duvall DianthaCHIEF FINANCIAL OFFICER | SSale | −24.4K | $0.0765 | −$1.87K | −24.1%76.7K after | |
| Apr 5, 2022 (view filing) | Apr 4 | 1 day | Flechtner Jessica BakerChief Scientific Officer | SSale | −1.21K | $1.25 | −$1.51K | −1.2%96.2K after | |
| Apr 5, 2022 (view filing) | Apr 4 | 1 day | Duvall DianthaCHIEF FINANCIAL OFFICER | SSale | −963 | $1.25 | −$1.20K | −1.0%91.8K after | |
| Apr 5, 2022 (view filing) | Apr 4 | 1 day | Davis Thomas AndrewCHIEF MEDICAL OFFICER | SSale | −1.09K | $1.25 | −$1.36K | −1.6%68.3K after | |
| Apr 5, 2022 (view filing) | Apr 4 | 1 day | Clark William DPresident and CEO | SSale | −3.92K | $1.25 | −$4.91K | −1.1%369.5K after | |
| Apr 5, 2022 (view filing) | Apr 4 | 1 day | Aakalu Girish NCHIEF BUSINESS OFFICER | SSale | −963 | $1.25 | −$1.20K | −1.3%74.5K after | |
| Mar 17, 2022 (view filing) | Mar 16 | 1 day | Flechtner Jessica BakerChief Scientific Officer | SSale | −3.35K | $1.10 | −$3.68K | −3.3%97.4K after | |
| Mar 17, 2022 (view filing) | Mar 16 | 1 day | Duvall DianthaCHIEF FINANCIAL OFFICER | SSale | −2.87K | $1.10 | −$3.16K | −3.0%92.7K after | |
| Mar 17, 2022 (view filing) | Mar 16 | 1 day | Davis Thomas AndrewCHIEF MEDICAL OFFICER | SSale | −2.72K | $1.10 | −$2.99K | −3.8%69.4K after | |
| Mar 17, 2022 (view filing) | Mar 16 | 1 day | Clark William DPresident and CEO | SSale | −11.4K | $1.10 | −$12.6K | −3.0%373.4K after | |
| Mar 17, 2022 (view filing) | Mar 16 | 1 day | Aakalu Girish NCHIEF BUSINESS OFFICER | SSale | −2.40K | $1.10 | −$2.64K | −3.1%75.4K after |